Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Leukemia|March 20, 2009
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyS Mustjoki, M Ekblom, T P Arstila, et al.
Leukemia|May 3, 2016
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patientsH Hjorth-Hansen, J Stentoft, J Richter, et al.
Leukemia|January 19, 2013
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patientsS Mustjoki, J Richter, G Barbany, et al.
Bone Marrow Transplantation|October 6, 2015
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myelomaR Silvennoinen, P Anttila, M Säily, et al.
Bone Marrow Transplantation|April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)B Björkstrand, H Svensson, H Goldschmidt, et al.
Leukemia & Lymphoma|December 1, 1996
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.
Blood|December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow TransplantationB B Björkstrand, P Ljungman, H Svensson, et al.
Leukemia|October 7, 2015
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st studyA Hochhaus, G Rosti, N C P Cross, et al.
Leukemia|November 29, 2016
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemiaM Ilander, U Olsson-Strömberg, H Schlums, et al.
Pageof 12